Mouse anti Human CD3 FITC - CD19 PE

CAT:
579-0319
Size:
100 Tests
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Mouse anti Human CD3 FITC - CD19 PE - image 1

Mouse anti Human CD3 FITC - CD19 PE

  • Background:

    The CD3 epitope is expressed on the epsilon chain of the CD3/T cell antigen receptor (TcR) complex. CD3 is present on 65-85% of thymocytes and has a mitogenic effect on peripheral blood T cells. Identification of Human T cells expressing the 22-28,000 M.W. surface antigen. Identification of CD19 Human B cells associated appoximately 10% of peripheral blood lymphocytes expressing 95,000 M.W. surface antigen
  • Synonyms:

    CD3 FITC - CD19 PE
  • UniProt:

    P07766, P15391
  • Host:

    Mouse
  • Species Reactivity:

    Human
  • Isotype:

    IgG1
  • Conjugation:

    Bi-Test (FITC/RPE) Reagent
  • Type:

    Bi-Testâ„¢ Reagents (FITC/RPE)
  • Source:

    Derived from the hybridization of mouse NS-1 myeloma celss with spleen cells from BALB/c mice immunized with Human thymocytes.
  • Applications:

    Flow Cytometry
  • Field of Research:

    Flow Cytometry
  • Purification Method:

    Protein A/G Chromatography
  • Assay Principle:

    PBMC: Add10 µL of MAB/10^6 PBMC in 100 µL PBS. Mix gently and incubate for 15 minutes at 2º to 8ºC. Wash twice with PBS and analyze or fix with 0.5% v/v of paraformaldehyde in PBS and analyze. _x000D_ WHOLE BLOOD: Add10 µL of MAB/100 µL of whole blood. Mix gently and incubate for 15 minutes at room temperature 20ºC. Lyse the whole blood. Wash once with PBS and analyze or fix with 0.5% v/v of paraformaldehyde in PBS and analyze. See instrument manufacturer’s instructions for Lysed Whole Blood and Immunofluorescence analysis with a flow cytometer or microscope.
  • Stability:

    See expiration date on vial
  • Concentration:

    Titered for flow cytometry
  • Form:

    Provided as solution in phosphate buffered saline with 0,08% sodium azide and 0,2% carrier protein
  • Precautions:

    This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving Humans or animals.
  • References & Citations:

    1. Knowles RW. Immunochemical analysis of the T cell-specific antigens. In : Reinhert EL, Haynes BF, Nadl LM and Bernstein ID. eds. Leukocyte Typing II, Human T Lymphocytes. New York, NY: Springer-Verlag; 1986:259_x000D_ 2. Kurrle R. Cluster Report:CD3. In:Knapp W, Dorken B, Gilks WR, Reiber EP, Schmidt RE, Stein H, and von dem Borne AEG Kr, eds. Leukocyte Typing IV, White cell Differentation Antigens. Oxford, England: Oxford Press 1989:293 _x000D_ 3. Signal transduction via CD4,CD8 and CD28 in mature and immature thymocytes. Implications for thymic selection. Turka LA, Linsley PS, Paine R 3d, Schieven Gl, Thompson GB, Ledbetter JA, J. Immunol. 1991 Mar :146(5): 1428-36 _x000D_ 4. T cell receptor/CD3-signaling induces death by apoptosis in Human T cell receptor gamma delta + Tcells. Janssen O, Wesselborg S, Heckl-Ostreicher B, Pechhold K, Bender A, Schondelmaier S, Moldenhauer G, Kabelitz D I Immunol. 1991 Jan146(1):35-9 _x000D_ 5. Clonal analysis of Human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus Hori T, Spits H J. Immunol. 1991 Apr 146(7):2116-21 6. Molecular cloning of the CD3 zeta subunit identifies a CD3 zeta-related product in thymus-derived cells Jin YJ, Claton LK, Howard FD, Koyasu S, Sieh M, Steinbrich R, Tarr GE, Reinherz EL. Proc Natl Acad Sci usa 1990 Ma: 87(9):3319-23 _x000D_ 7. Functional Properties of CD19+ B Lymphocytes Positively Selected from Buffy Coats by Immunomagnetic Separation. Funderud S., Erikstien B., Asheim H.C., Nustad K., Stokke T., Blomhoff H.K., Holte H, Smeland E.B., Eur. J. Immunol. 1990 Ja;20(1):201-6_x000D_ 8. Thymic B Cells from Myasthenia Gravis Patients are Activated B Cells. Phenotypic and Functional Analysis. Leprince C., CohenKaminsky S., Berrih-Aknin S., Vernet-Der Garabedian B., Treton D., Galanaud P., Richard Y., J. Immunol. 1990 Oct., 145(7):2115-22_x000D_ 9. Prognostic Significance of CD34 Expression in Childhood B Precursor Acute Lymphocytic Leukemia: A Pediatric Onocology Group Study. Borowitz MJ, Shuster JJ, Civin CI, Carrol AJ, Look AT, Behm FG, Land VJ, Pullen DJ, Crist WM, J. Clin. Onol. 1990 Au;8(8):1389-98_x000D_ 10. Biphenotypic Acute Leukemia in Adults. Sulak LE, Clare CN, Morale BA, Hansen KL, Montiel MM, Am. J. Clin. Path. 1990 Ju;94(1):54-8 _x000D_ 11. Intersection of the Complement and Immune Systems: A Signal Transduction Complex of the B Lymphocyte Containing Complement Receptor type 2 and CD19. Matsumoto AK, Kopicky-Burd J., Carter Rh, Tuveson DA, Tedder TF, Fearon, DT, J. Exp. Med. 1991 Jan. 173(1):55-64
  • Shipping Conditions:

    Ambient Temperature
  • Storage Conditions:

    Product should be stored at 4-8ºC; DO NOT FREEZE
  • Functional Analysis:

    Flow Cytometry Staining
  • CAS Number:

    9007-83-4